Roivant Sciences Ltd.
ROIV
Peringkat dalam Saham
#963
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Harga Saham
$33.73
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$24.37B
Perubahan (1 hari)
-2.28%
Perubahan (1 tahun)
87.82%
Negara
GB
Perdagangan Roivant Sciences Ltd. (ROIV)
Kategori
Healthcare
Riwayat harga saham Roivant Sciences Ltd. (ROIV)
Harga penutupan tertinggi: $34.87 pada 2026-07-01
Harga penutupan terendah: $10.07 pada 2020-12-01
Harga penutupan terendah: $10.07 pada 2020-12-01
Riwayat harga saham Roivant Sciences Ltd. dari 2020 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 23.70% |
| 2025 | 80.37% |
| 2024 | 13.38% |
| 2023 | 50.58% |
| 2022 | -31.41% |
| 2021 | 1.51% |
| 2020 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
